ClinicalTrials.gg
RecruitingNCT07820696OLAX-CRCUpdated Sep 15, 2026

Effect of Oral Laxative Use Before Colorectal Surgery on Intraoperative Surgical Difficulty

An interventional study of Oral Laxative and Rectal Enema in Colorectal Diseases and Mechanical Bowel Preparation, sponsored by Van Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-15.

Sponsored by Van Training and Research Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled May 2026, registered Sep 2026).
  • Started May 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This prospective randomized pilot study will evaluate whether the use of an oral laxative before elective laparoscopic colorectal surgery affects small-bowel diameter and intraoperative surgical difficulty. Adult patients scheduled for elective laparoscopic colorectal resection will be randomly assigned to receive either oral laxative plus rectal enema preparation or rectal enema preparation alone. During surgery, the diameters of the jejunum and ileum will be measured using a standardized method. The study will also compare operative difficulty, bowel manipulation time, operation duration, need for additional ports, conversion to open surgery, intraoperative complications, blood loss, and early postoperative outcomes between the two groups. The findings may help clarify whether oral laxative use influences intraoperative conditions during laparoscopic colorectal surgery.

Read the detailed description

Mechanical bowel preparation is commonly used before elective colorectal surgery. Although its effects on postoperative outcomes have been widely investigated, limited evidence is available regarding the effect of oral laxatives on intraoperative small-bowel distension and technical difficulty during laparoscopic colorectal surgery. Increased intraluminal fluid following oral laxative administration may lead to small-bowel distension, potentially impairing surgical exposure and increasing the need for bowel manipulation.

In this study, small-bowel diameter will be assessed intraoperatively using a standardized measurement method after laparoscopic access and establishment of pneumoperitoneum. Jejunal diameter will be measured approximately 50 cm distal to the ligament of Treitz, and ileal diameter approximately 20 cm proximal to the ileocecal valve. Measurements will be performed in the transverse plane without applying mesenteric tension and, when feasible, the mean of two measurements will be recorded. At the end of the operation, the operating surgeon will assess overall operative difficulty using a Likert-type scale ranging from very easy to very difficult. This pilot study is intended to provide preliminary evidence for the design of future adequately powered studies and to support the evaluation of current bowel-preparation practices.

02

Conditions studied

  • Colorectal Diseases
  • Mechanical Bowel Preparation

Keywords

  • Colorectal Surgery
  • Mechanical Bowel Preparation
  • Oral Laxative
  • Randomized Controlled Trial
  • Laparoscopic Surgery
03

In context

Lead sponsor

Van Training and Research Hospital is the lead sponsor of 8 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Scheduled for elective laparoscopic colorectal resection
  • (ASA) physical status I-III
  • Able and willing to provide written

Exclusion criteria

Exclusion Criteria:

  • Requirement for emergency surgery
  • Mechanical intestinal obstruction, gastrointestinal perforation, or generalized peritonitis
  • Anticipated extensive intra-abdominal adhesions
  • Active inflammatory bowel disease
  • Pregnancy
  • Serious systemic disease constituting a to oral laxative use
  • Inability to perform standardized intraoperative small-bowel diameter measurements
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Oral Laxative Plus Rectal Enema

    Participants assigned to this arm will receive preoperative bowel preparation consisting of an oral laxative combined with a rectal enema before elective laparoscopic colorectal surgery.

    Drug: Oral Laxative · Drug: Rectal Enema

  • Active comparator
    Rectal Enema Alone

    Participants assigned to this arm will receive preoperative bowel preparation consisting of a rectal enema alone, without an oral laxative, before elective laparoscopic colorectal surgery.

    Drug: Rectal Enema

Interventions

  • DrugOral Laxative

    Participants assigned to the experimental arm will receive an oral laxative as part of preoperative mechanical bowel preparation, in addition to a rectal enema, before elective laparoscopic colorectal surgery. The oral laxative will be administered according to the institution's standard preoperative bowel preparation protocol.

  • DrugRectal Enema

    Participants in both study arms will receive a rectal enema as part of preoperative bowel preparation before elective laparoscopic colorectal surgery. Participants in the comparator arm will receive the rectal enema without an oral laxative.

06

What researchers measure

Primary outcomes

  1. Intraoperative Jejunal Diameter

    Jejunal diameter will be measured in centimeters approximately 50 cm distal to the ligament of Treitz, in the transverse plane, under standard pneumoperitoneum pressure and without applying mesenteric tension. When feasible, two measurements will be obtained and their mean will be recorded.

    Time frame: Intraoperatively, after laparoscopic access and establishment of pneumoperitoneum

  2. Intraoperative Ileal Diameter

    Ileal diameter will be measured in centimeters approximately 20 cm proximal to the ileocecal valve, in the transverse plane, under standard pneumoperitoneum pressure and without applying mesenteric tension. When feasible, two measurements will be obtained and their mean will be recorded.

    Time frame: Intraoperatively, after laparoscopic access and establishment of pneumoperitoneum

Secondary outcomes

  1. Operative Difficulty Score

    Overall operative difficulty will be assessed by the operating surgeon at the end of the procedure using a 5-point Likert scale: 1 = very easy, 2 = easy, 3 = moderate, 4 = difficult, and 5 = very difficult. Higher scores indicate greater operative difficulty.

    Time frame: At the end of surgery, on the day of the procedure

  2. Estimated Intraoperative Blood Loss

    The estimated volume of blood lost during surgery, as recorded in the operative and anesthesia records.

    Time frame: Intraoperatively, on the day of surgery

  3. Incidence of Intraoperative Serosal Injury

    The number of participants who experience an unintended serosal injury during surgery, as documented in the operative record.

    Time frame: Intraoperatively, on the day of surgery

  4. Incidence of Intraoperative Organ Injury

    The number of participants who experience an unintended injury to an intra-abdominal organ during surgery, as documented in the operative record.

    Time frame: Intraoperatively, on the day of surgery

  5. Incidence of Intraoperative Bleeding Requiring Intervention

    The number of participants who experience intraoperative bleeding requiring an additional hemostatic intervention beyond routine surgical hemostasis.

    Time frame: Intraoperatively, on the day of surgery

  6. Requirement for an Additional Laparoscopic Port

    The number of participants in whom placement of at least one additional laparoscopic port beyond the planned port configuration is required to complete the procedure.

    Time frame: Intraoperatively, on the day of surgery

  7. Conversion From Laparoscopic to Open Surgery

    The number of participants whose planned laparoscopic procedure is converted to an open surgical approach.

    Time frame: Intraoperatively, on the day of surgery

  8. Incidence of Any Postoperative Complication Within 30 Days

    The number of participants who experience at least one surgery-related postoperative complication within 30 days after surgery. Each participant will be counted once, regardless of the number of complications experienced.

    Time frame: From the day of surgery through postoperative day 30

  9. Incidence of Anastomotic Leakage Within 30 Days

    The number of participants who develop an anastomotic leak within 30 days after surgery, as documented by clinical, radiological, endoscopic, operative, or drainage findings.

    Time frame: From the day of surgery through postoperative day 30

  10. Incidence of Surgical Site Infection Within 30 Days

    The number of participants who develop a surgical site infection within 30 days after surgery, including superficial incisional, deep incisional, or organ/space infection.

    Time frame: From the day of surgery through postoperative day 30

  11. Incidence of Postoperative Ileus Within 30 Days

    The number of participants who develop postoperative ileus within 30 days after surgery, as documented in the medical record based on delayed recovery or interruption of gastrointestinal function.

    Time frame: From the day of surgery through postoperative day 30

  12. Time Required for Bowel Manipulation and Displacement

    The time required to manipulate the bowel and displace it from the operative field during surgery.

    Time frame: Intraoperatively, on the day of surgery

  13. Time Required for Intraoperative Bowel Diameter Measurements

    The time required to perform intraoperative measurements of the jejunal and ileal diameters.

    Time frame: Intraoperatively, on the day of surgery

  14. Time Required to Complete the Anastomosis

    The time from initiation of anastomosis construction to completion of the anastomosis during surgery.

    Time frame: Intraoperatively, on the day of surgery

  15. Total Operation Time

    The total duration of the surgical procedure, defined as the time from skin incision to completion of skin closure.

    Time frame: Intraoperatively, on the day of surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2026 (actual). Primary completion is estimated for May 2027, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 5, 2026
First posted
Sep 15, 2026
StartActual
May 22, 2026
Primary completionEst.
May 22, 2027
CompletionEst.
Jun 22, 2027
Last update
Sep 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07820696
Lead sponsor
Van Training and Research Hospital
Responsible party
IBRAHIM DOGAN (MD, Van Training and Research Hospital) — Principal investigator
First posted
Sep 15, 2026
Start date
May 22, 2026
Primary completion
May 22, 2027 (estimated)
Completion
Jun 22, 2027 (estimated)
Last update
Sep 15, 2026

Study contacts

İbrahim Doğan
Contact
dogan_203@hotmail.com
+905313884966

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion